Table 2.
Categorical variable | No SpaceOAR | SpaceOAR | Total | p-value* | ||||
---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | |||
Clinical stage | T1c | 134 | 77.0 | 123 | 70.7 | 257 | 73.8 | 0.349 |
T2a | 26 | 14.9 | 34 | 19.5 | 60 | 17.2 | ||
T2b | 9 | 5.2 | 8 | 4.6 | 17 | 4.9 | ||
T2c | 5 | 2.9 | 4 | 2.3 | 9 | 2.6 | ||
T3a,b,c | 0 | 0.0 | 5 | 2.9 | 5 | 1.4 | ||
103Pd implant Rx dose (Gy) | 80 | 90 | 51.7 | 106 | 60.9 | 196 | 56.3 | 0.005 |
90 | 22 | 12.6 | 34 | 19.5 | 56 | 16.1 | ||
115 | 29 | 16.7 | 22 | 12.6 | 51 | 14.7 | ||
125 | 33 | 19.0 | 12 | 16.9 | 45 | 12.9 | ||
NCCN Risk Group | Low | 3 | 1.7 | 0 | 0.0 | 3 | 0.9 | 0.061 |
Intermediate | 119 | 68.4 | 113 | 64.9 | 232 | 66.7 | ||
High | 52 | 29.9 | 57 | 32.8 | 109 | 31.3 | ||
Very high | 0 | 0.0 | 4 | 2.3 | 4 | 1.2 | ||
Diabetes | No | 173 | 99.4 | 174 | 100.0 | 347 | 99.7 | 0.317 |
Yes | 1 | 0.6 | 0 | 0.0 | 1 | 0.3 | ||
Hypercholesterolemia | No | 172 | 98.8 | 174 | 100.0 | 346 | 99.4 | 0.156 |
Yes | 2 | 1.2 | 0 | 0.0 | 2 | 0.6 | ||
Hypertension | No | 171 | 98.3 | 174 | 100.0 | 345 | 99.1 | 0.082 |
Yes | 3 | 1.7 | 0 | 0.0 | 3 | 0.9 |
Chi-squared test, p-values ≤ 0.5 in bold